AKT1 Protein

v-akt murine thymoma viral oncogene homolog 1

AKT1 Products

AKT1 Protein, Recombinant

Molecule	Species	Description	Cat. No
AKT1	Human	AKT1 Protein, Recombinant	10763-H08B

  10763-H08B:  Measured by its ability to bind biotinylated human CD136 in a functional Elisa.

AKT1 cDNA Clone

Molecule	Species	Description	Cat. No
AKT1	Human	Homo sapiens AKT1 cDNA Clone	HG10763-G
AKT1	Mouse	Mus musculus AKT1 cDNA Clone	MG50254-M

AKT1 Related Areas

Enzyme>>Protein Kinase>>Intracellular Kinase>>Akt/PKB>>AKT1

Signal Transduction>>Protein Kinase>>Intracellular Kinase>>Akt/PKB>>AKT1

AKT1 Alternative Names

AKT1, AKT, PKB-ALPHA, PRKBA, MGC99656, PKB, RAC, RAC-ALPHA, RAC-PK-alpha [Homo sapiens]

Akt1, Akt, PKB, PKBalpha, PKB/Akt, Rac [Mus musculus]

AKT1 Background

v-akt murine thymoma viral oncogene homolog 1 (AKT1), or protein kinase B-alpha (PKB-ALPHA) is a serine-threonine protein kinase, belonging to the Protein Kinase Superfamily. AKT1 is a major mediator of the responses to insulin, insulin-like growth factor 1 (IGF1), and glucose. AKT1 also plays a key role in the regulation of both muscle cell hypertrophy and atrophy. AKT1 activity is required for physiologic cardiac growth in response to IGF1 stimulation or exercise training. In contrast, AKT1 activity was found to antagonize pathologic cardiac growth that occurs in response to endothelin 1 stimulation or pressure overload. AKT1 selectively promotes physiological cardiac growth while AKT2 selectively promotes insulin-stimulated cardiac glucose metabolism. AKT1 deletion prevented tumor initiation as well as tumor progression, coincident with decreased Akt signaling in tumor tissues. AKT1 is the primary Akt isoform activated by mutant K-ras in lung tumors, and that AKT3 may oppose AKT1 in lung tumorigenesis and lung tumor progression. A number of separate studies have implicated AKT1 as an inhibitor of breast epithelial cell motility and invasion. AKT1 may have a dual role in tumorigenesis, acting not only pro-oncogenically by suppressing apoptosis but also anti-oncogenically by suppressing invasion and metastasis.

AKT1 Related Studies

1. Hollander MC, et al. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene. 30(15): 1812-21.
2. Devaney JM, et al. (2011) AKT1 polymorphisms are associated with risk for metabolic syndrome. Hum Genet. 129(2): 129-39.
3. Dillon RL, et al. (2010) Distinct biological roles for the akt family in mammary tumor progression. Cancer Res. 70(11): 4260-4.
4. Toker A, et al. (2006) Akt signaling and cancer: surviving but not moving on. Cancer Res. 66(8): 3963-6.
5. Muslin AJ, et al. (2006) Role of Akt in cardiac growth and metabolism. Novartis Found Symp. 274: 118-26.